Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

DTwP-HepB-Hib vaccine - Crucell/Novartis Vaccines

Drug Profile

DTwP-HepB-Hib vaccine - Crucell/Novartis Vaccines

Alternative Names: DTP-HepB-Hib; DTwP-HepB-Hib; Fully liquid 5-in-1 pentavalent vaccine (Quinvaxem) - Crucell; Quinvaxem

Latest Information Update: 12 May 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Berna Biotech; Novartis Vaccines
  • Developer Crucell; Novartis Vaccines
  • Class Bacterial vaccines; Conjugate vaccines; Haemophilus vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 01 Apr 2014 Crucell completes a phase III trial in Diphtheria, Pertussis, Tetanus, Hepatitis B and Haemophilus Infections (prevention, in infants) in the Philippines (NCT01917357)
  • 05 Aug 2013 Crucell plans a phase III trial for Diphtheria, Pertussis, Tetanus, Hepatitis B and Haemophilus Infections (prevention, in infants) in Philippines (NCT01917357)
  • 31 Dec 2011 Phase-III clinical trials in Diphtheria (prevention, in infants) in India (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top